Pharmaceutical service provider PCI Clinical Services has grown its cryogenic storage capabilities in Rockford, Illinois, by 400%.

The move follows the company’s initial capital investment in specialist cryogenic storage at the site in November 2016 and is said to complement its existing liquid nitrogen (N2) storage capabilities at its centre in Bridgend, UK.

The expansion includes the installation of larger-scale specialised storage to allow for more versatile storage configurations and is the latest in a series of major investments by the US-based business in supporting clinical trial supply.

The additional capacity is situated in a 93,000-square foot building at PCI’s Rockford campus. The new site is now one of seven facilities at the Rockford centre of excellence.

PCI’s General Manager of US Clinical Services Brian Keesee underlined, “We have a proven track record with dry ice and N2 shipping and storage systems, an extensive global distribution network and expertise in handling, storage and distribution of temperature-sensitive products.”

“We have a proven track record with dry ice and nitrogen shipping and storage systems”

Brian Keesee, General Manager of US Clinical Services

“PCI’s continued investment in clinical trial services ensures a robust supply chain for our clients; our dual-site set up allows highly-flexible, high-capacity storage options.”

As well as the expansion of its initial cryogenic storage facilities to the US last year, PCI also extended its Bridgend site with a dedicated -40°C facility, introduced a broader cold chain capacity that increased site storage by over 400% and continued expansion of frozen storage at -80°C.

PCI is an integrated full service provider and serves leading companies in the global healthcare industry.